Dr. Strati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 507-284-2511
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2014 - 2016- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2012 - 2014
Universita San RaffaeleClass of 2008
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2022 - 2026
GA State Medical License 2022 - 2026
TN State Medical License 2022 - 2026
WA State Medical License 2022 - 2026
LA State Medical License 2022 - 2025
MS State Medical License 2022 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Acalabrutinib, Lenalidomide, and Rituximab for the Treatment of CD20 Positive Stage III-IV, Grade 1-3a Follicular Lymphoma Start of enrollment: 2020 Jul 16
- Anakinra for the Reduction of CAR-T Toxicity in Patients With Relapsed or Refractory Large B-cell Lymphoma Start of enrollment: 2020 Jul 27
- A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy Start of enrollment: 2022 Sep 23
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- Ultra-Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung.Susan Y Wu, Penny Q Fang, Ahmed Fetooh, Gohar S Manzar, Kelsey L Corrigan
Advances in Radiation Oncology. 2024-12-01 - Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type: A Role for Elective Nodal Irradiation?Penny Fang, Sonal S Noticewala, Susan Y Wu, Jillian R Gunther, Ethan B Ludmir
Advances in Radiation Oncology. 2024-12-01 - Acalabrutinib alone or in combination with rituximab for follicular lymphoma: An open-label study.Paolo Strati, Rebecca Champion, Morton Coleman, Sonali M Smith, Parameswaran Venugopal
British Journal of Haematology. 2024-12-01
Abstracts/Posters
- A Phase I/II Study of Lenalidomide Plus Obinutuzumab in Relapsed Indolent LymphomaPaolo Strati, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Radiation Therapy Can be an Effective Bridging Strategy Prior to Axicabtagene Ciloleucel Therapy for Relapsed/Refractory Large B-Cell LymphomaRadiation Therapy Can be ...Paolo Strati, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Prognostic value of baseline SUV in patients with advanced stage follicular lymphoma receiving frontline rituximab-based therapy.ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- Hematopoietic recovery and immune reconstitution after axi-cel CAR T-cell therapy in patients with relapsed/refractory large B-cell lymphoma.ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- Predictive Factors of Response and Survival of Lenalidomide and Rituximab As Initial Treatment of Follicular Lymphoma61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Press Mentions
Crystal Ball Cloudy for PI3K Inhibitors' Future in HematologyJanuary 2nd, 2023- MD Anderson Research Highlights: EHA 2022 Special EditionJune 8th, 2022
- MD Anderson Research Highlights: ASH 2021 Special EditionDecember 8th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
